The Venture Codex Logo

The Venture Codex

Shanghai Biopharmaceutical Fund

Huangpu, Shanghai, China

Overview

Investment fund focusing on the biomedical industry development.

Founded

2020

Deals ยท 12mo

0

Links

Website

Stage focus

Series A
Series C

Geographic focus

China
South Africa

Sector focus

Biotechnology
Finance
Financial Services
Impact Investing

Investment portfolio

3rounds
NAMEDATESIZE
AccuPulse
Feb 2024Led
$28 MSeries A
AccuPulse
May 2022Participated
$10 MSeries A
Meditrust
Aug 2021Participated
$309 MSeries C
AccuPulse
Feb 2024Led
$28 MSeries A
AccuPulse
May 2022Participated
$10 MSeries A
Meditrust
Aug 2021Participated
$309 MSeries C
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Shanghai Biopharmaceutical Fund: 3 funding rounds are recorded in the selected participation categories.All available history.
Shanghai Biopharmaceutical Fund: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A11
Series C+01

Monthly Deal Activity

Shanghai Biopharmaceutical Fund: 3 deals are recorded across 63 months.All available history.
Shanghai Biopharmaceutical Fund: 3 deals are recorded across 63 months. All available history
MonthDeals
Aug '211
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Shanghai Biopharmaceutical Fund: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Shanghai Biopharmaceutical Fund: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Fintech1
Professional Services1

Deal Size Distribution

Shanghai Biopharmaceutical Fund: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Shanghai Biopharmaceutical Fund: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Shanghai Biopharmaceutical Fund: China has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Shanghai Biopharmaceutical Fund: China has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
China2
South Africa1
Shanghai Biopharmaceutical Fund: 14 co-investors are shown, with AIHC Capital sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Shanghai Biopharmaceutical Fund: 14 co-investors are shown, with AIHC Capital sharing 1 recorded deals. All available history
Co-investorShared deals
AIHC Capital1
Bank of China Group Investment1
Boyu Capital1
China Everbright1
China Renaissance1
CICC Capital1
Janchor Partners1
Lake Bleu Capital1
Lilly Asia Ventures1
Marathon Venture Partners1
New Alliance Capital1
Shengshi Investment Management1
Shenzhen Qianhai Capital1
Sinovation Ventures1

Investment Strategy

Shanghai Biopharmaceutical Fund: Led accounts for 33% and participating for 67% of round participation.All available history.
Shanghai Biopharmaceutical Fund: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
Shanghai Biopharmaceutical Fund: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Shanghai Biopharmaceutical Fund: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

No team members found for this fund.